Narrow search
Showing 1 - 10 of 11,631
Cover Image
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017
Persistent link: https://www.econbiz.de/10011708133
Cover Image
The EU's open strategic autonomy in the field of pharmaceuticals : overcoming import dependencies for antibiotics through the EU authority HERA
Bayerlein, Michael - Stiftung Wissenschaft und Politik - 2023
The COVID-19 pandemic and war in Ukraine have highlighted the dependence of the European Union (EU) on individual trading partners. One of the tasks of the European Commission’s new Directorate-General, the Health Emergency Preparedness and Response Authority (HERA), established in 2021, will...
Persistent link: https://www.econbiz.de/10013540432
Cover Image
Is Europe a Laggard in Pharmaceuticals? R&D Joint Ventures, Patent Quality and R&D Productivity
Messinis, George - 2009
‘performed' R&D and ‘extra-mural' R&D, and focuses on R&D productivity and patent quality as key indicators of innovation. The …
Persistent link: https://www.econbiz.de/10013155663
Cover Image
Pharmaceutical spending and early-stage innovation in EU countries
Kourouklis, Dimitrios; Gandjour, Afschin - In: Industry and innovation 29 (2022) 10, pp. 1141-1170
Persistent link: https://www.econbiz.de/10013493053
Cover Image
Which policies for vaccine innovation and delivery in Europe?
Dewatripont, Mathias - 2022 - Revised, April 2022
Persistent link: https://www.econbiz.de/10013208383
Cover Image
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - In: Review of industrial organization : RIO 53 (2018) 1, pp. 173-210
Persistent link: https://www.econbiz.de/10012009103
Cover Image
Which policies for vaccine innovation and delivery in Europe?
Dewatripont, Mathias - In: International journal of industrial organization 84 (2022), pp. 1-14
Persistent link: https://www.econbiz.de/10013435474
Cover Image
Smart Innovation and Inclusive Patents for Sustainable Food and Health Care : Redefining the Europe 2020 Objectives
Van Overwalle, Geertrui - 2015
Various remedies have been suggested to deal with potential hindering effects of patents in the area of plant and human biotechnology – two areas which show remarkable linkages and share similar problems. What many of these suggestions have in common, is their call for a more responsible...
Persistent link: https://www.econbiz.de/10014147618
Cover Image
Big Pharma, little science? : a bibliometric perspective on Big Pharma's R&D decline
Rafols, Ismael; Hopkins, Michael M.; Hoekman, Jarno; … - In: Technological forecasting & social change : an … 81 (2014), pp. 22-38
Persistent link: https://www.econbiz.de/10010403289
Cover Image
Innovation and industrial leadership: lessons from pharmaceuticals
Pammolli, Fabio; Riccaboni, Massimo - 2007
Persistent link: https://www.econbiz.de/10009316600